Our expert says:
The use of highly purified versus recombinant stimulation drugs depends on indivudal circumstances including the patient’s age, previous responses to IVF treatment, baseline hormone evaluation of ovarian reserve, ovarian antral follicle count and the level of active and volume of the ovaries. In addition the presence and absence of polycystic ovarian syndrome will also influence the choice of IVF stimulatory drugs. Therefore it is not a question of which drug is superior but rather which drug is the more appropriate in a particular treatment program.
Answered by: Dr. M.I. Cassim
The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal
advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.